Future studies are required to investigate whether DTX3L might also act independently of ARTD9 together with DTX1 in non-canonical NOTCH1/2-Deltex1-dependent PI3K/AKT signaling pathways in HR subtype DLBCL. The gene discussed is DTX3L; the disease is diffuse large B-cell lymphoma.